Women's Health Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Journal of the National Cancer Institute
Nonhormonal treatment regimens improve survival in patients with metastatic breast cancer
December 25th, 2008
Nonhormonal treatment regimens, including anthracycline-based regimens and taxanes, have improved overall survival in women with advanced (metastatic or recurrent inoperable) breast cancer over the last 35 years, according to a systematic review published December 9 in the Journal of the National Cancer Institute. Numerous regimens have been tested in advanced breast cancer. However, each of the trials has compared only a few regimens, making it difficult for researchers and clinicians to know the relative merit of the individual regimens. To learn how regimens compare with one another, John P. A. Ioannidis, M.D., of the University of Ioannina School...
Source: Women's Health Weekly (2008-12-25)
|
